DUBAI (July 11, 2022) – Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, has launched ENTEROSURE™ to control the growth of pathogenic bacteria in poultry and livestock. Kemin unveiled its latest intestinal health product at a global launch event in Dubai. The company’s newest probiotic solution promotes a healthy microbiome, drives intestinal resilience, manages gut health challenges and improves animal productivity.
Enteric disease challenges are an ever-present pressure on livestock and poultry producers, who are already facing significant performance and economic impact from the global trend toward reduced antimicrobial use and the rising cost of raw materials. These challenges require an effective and comprehensive solution that helps drive intestinal resilience to prevent disease before it develops—all while safeguarding animal health, welfare, growth and performance.
“Leveraging the pioneering research that launched CLOSTAT™, our novel solution addresses the changing needs of animal producers,” said G.S. Ramesh, Worldwide Group President – Animal Nutrition and Health, Kemin Industries. “ENTEROSURE, through its proprietary blend of probiotic Bacillus strains, expands on the scientifically proven efficacy of CLOSTAT’s Bacillus subtilis PB6 against Clostridium perfringens by also managing the growth of Escherichia coli and other Enterobacteriaceae, such as Salmonella.”
Intestinal resilience is a crucial factor in producers’ hierarchy of needs for their animals; up to 80 percent of antimicrobial use is intended to achieve resilience in the gastrointestinal system, a vital component in animal production. Kemin continues to drive innovation through its probiotic research program to support intestinal health management.
The company undertook a multiyear, global project to discover advanced solutions to enhance intestinal resilience while maintaining a robust program to improve feed conversion and weight gain and combat pathogens that contribute to dysbiosis, diarrhea, wet litter issues, foot-pad lesions and mortality.
About Kemin Industries
Kemin Industries (www.kemin.com) is a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services. The company supplies over 500 specialty ingredients for human and animal health and nutrition, pet food, aquaculture, nutraceutical, food technologies, crop technologies, textile, biofuel, and animal vaccine industries.
For over half a century, Kemin has been dedicated to using applied science to address industry challenges and offer product solutions to customers in more than 120 countries. Kemin provides ingredients to feed a growing population with its commitment to the quality, safety and efficacy of food, feed and health-related products.
Established in 1961, Kemin is a privately held, family-owned-and-operated company with more than 3,000 global employees and operations in 90 countries, including manufacturing facilities in Belgium, Brazil, China, Egypt, India, Italy, San Marino, Singapore, South Africa and the United States.